Protecting particles that carry mRNA in dry vaccine patches
09 July, 2026Combining expertise from RMIT University, MIT and Harvard Medical School, scientists set out to provide practical guidance for future mRNA dry vaccine patch design.
Copper drug clears Alzheimer's proteins — lab experiments reveal
03 July, 2026A drug that delivers copper to the brain has been found to significantly reduce Alzheimer's proteins and improve long-term spatial memory.
Scientists search for cystitis pain 'off switch'
02 July, 2026By targeting certain pain receptors in the bladder, Australian scientists believe that the effects of cystitis — an inflammation of the bladder — could be reduced.
Could this psychedelic compound reduce post-concussion symptoms?
25 June, 2026Few effective therapies exist for concussion. Now, an Australian clinical trial is exploring whether a psychedelic compound found in some mushrooms could help.
Turning point — optimal antibiotics for golden staph bloodstream infections
18 June, 2026Involving more than 150 hospitals across more than 14 countries, a global clinical trial supports a rethink of the default treatment for MSSA and PSSA infections.
Alloy implants that naturally dissolve after healing
04 June, 2026Australian researchers have been developing biodegradable magnesium-based alloys that more closely match the mechanical properties of human bone.
Partnership eyes up gene-editing approaches to vision loss
03 June, 2026A partnership will build on Australian ophthalmic research into mechanisms that damage nerve cells connecting the retina to the brain, leading to irreversible blindness.
Irregular blood pressure patterns and dementia-associated brain changes
29 May, 2026Hypertension has long been recognised as a risk factor for cognitive decline, yet the impact of blood pressure changes throughout the day has been less understood.
AusBiotech partners with Tenmile
28 May, 2026Designed to support Australia's homegrown life sciences innovation, AusBiotech has announced a strategic partnership with a specialist health technology investor.
Australian CDC issues update in wake of Ebola outbreak
21 May, 2026After the WHO determined the outbreak of Ebola in the DRC and Uganda to be a public health emergency of international concern, an update on risk to Australia has been released.
Multiple myeloma treatment reprograms patients' own immune cells
21 May, 2026An Australian and Victorian Government funding agreement has allowed eligible Australians with multiple myeloma access to a tailor-made blood cancer treatment.
Australia announces $7.2m diphtheria outbreak response package
21 May, 2026To respond to the biggest diphtheria outbreak on record, support has been announced for the NT Government and the Aboriginal Community Controlled Health Sector.
MV Hondius passengers return to Australia under strict infection control measures
14 May, 2026The Australian CDC has provided an update on hantavirus risk to Australians and infection protection and control measures for returning MV Hondius passengers.
Cancer research and clinical trials at the core of new centre
07 May, 2026The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been launched by Monash University and The Alfred.
Potential biological targets for vascular dementia
01 May, 2026Caused by damage to blood vessels in the brain, there is currently no approved treatment for vascular dementia. Could genetics-led approaches offer pathways?
